TESTAI, LARA
 Distribuzione geografica
Continente #
NA - Nord America 8102
EU - Europa 3841
AS - Asia 1168
AF - Africa 63
SA - Sud America 23
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13209
Nazione #
US - Stati Uniti d'America 7844
IT - Italia 1351
SE - Svezia 752
CN - Cina 706
DE - Germania 484
BG - Bulgaria 439
CA - Canada 256
VN - Vietnam 205
GB - Regno Unito 172
TR - Turchia 164
AT - Austria 149
UA - Ucraina 129
FI - Finlandia 124
FR - Francia 91
RU - Federazione Russa 50
CI - Costa d'Avorio 45
BE - Belgio 33
IN - India 25
NL - Olanda 16
NG - Nigeria 15
BR - Brasile 14
IR - Iran 11
SG - Singapore 9
AU - Australia 8
CH - Svizzera 8
HK - Hong Kong 8
KR - Corea 8
PK - Pakistan 8
PL - Polonia 8
CL - Cile 7
GR - Grecia 5
ES - Italia 4
HU - Ungheria 4
JP - Giappone 4
SK - Slovacchia (Repubblica Slovacca) 4
UZ - Uzbekistan 4
HR - Croazia 3
KZ - Kazakistan 3
LU - Lussemburgo 3
CZ - Repubblica Ceca 2
EU - Europa 2
IL - Israele 2
MX - Messico 2
NO - Norvegia 2
RS - Serbia 2
SA - Arabia Saudita 2
TW - Taiwan 2
ZA - Sudafrica 2
A1 - ???statistics.table.value.countryCode.A1??? 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
ID - Indonesia 1
IE - Irlanda 1
IQ - Iraq 1
IS - Islanda 1
LK - Sri Lanka 1
MY - Malesia 1
NZ - Nuova Zelanda 1
RO - Romania 1
TN - Tunisia 1
UY - Uruguay 1
Totale 13209
Città #
Woodbridge 1288
Fairfield 966
Ann Arbor 882
Houston 837
Chandler 781
Serra 494
Sofia 439
Ashburn 361
Seattle 355
Wilmington 351
Cambridge 318
Beijing 297
Ottawa 239
Princeton 186
Jacksonville 171
Lawrence 171
Vienna 146
Izmir 145
Medford 133
Nanjing 125
Des Moines 108
Frankfurt am Main 86
Dong Ket 81
London 66
Dearborn 60
San Diego 50
Nanchang 48
Abidjan 45
Redwood City 41
Boulder 40
Grafing 39
Marseille 38
Brussels 32
Milan 32
Pisa 26
Hebei 25
Jüchen 25
Kunming 24
Shenyang 24
Norwalk 23
Rome 21
Jiaxing 20
Bremen 18
Changsha 18
Hangzhou 18
Nürnberg 18
Falls Church 17
Lancaster 17
Tianjin 17
Auburn Hills 15
Boardman 15
Guangzhou 15
Lagos 15
Livorno 14
Hefei 13
Florence 12
Jinan 9
New York 9
Toronto 8
Incisa 7
Indiana 7
Istanbul 7
Los Angeles 7
Napoli 7
Pontedera 7
Scafati 7
Shanghai 7
Vicopisano 7
Amsterdam 6
Bologna 6
Detroit 6
Islamabad 6
Kocaeli 6
Orange 6
Pieve 6
Redmond 6
San Francisco 6
Haikou 5
Massa Marittima 5
Montalto Di Castro 5
Pistoia 5
San Mateo 5
Siena 5
Viareggio 5
Changchun 4
Dallas 4
Hackensack 4
Lanzhou 4
Massarosa 4
Melbourne 4
Palermo 4
San Giorgio Jonico 4
São Paulo 4
Abbiategrasso 3
Berlin 3
Bibbona 3
Camaiore 3
Capannori 3
Caserta 3
Castelliri 3
Totale 10096
Nome #
Rimedi fitoterapici per la sindrome dell’ovaio policistico. Review di clinical trials 215
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 203
Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of brassicaceae? 165
The Citrus Flavanone Naringenin Protects Myocardial Cells against Age-Associated Damage 159
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 158
Nuovi attivatori dell’enzima SIRT1 per il trattamento delle patologie cardiovascolari e cardiometaboliche 153
The citrus flavanone naringenin produces cardioprotective effects in hearts from 1 year old rat, through activation of mitoBK channels 146
Antioxidant and Antisenescence Effects of Bergamot Juice 146
The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury 145
New NO-Releasing Pharmacodynamic Hybrids of Losartan and Its Active Metabolite: Design,Synthesis, and Biopharmacological Properties 144
The Citrus Flavonoid Naringenin Protects the Myocardium from Ageing-Dependent Dysfunction: Potential Role of SIRT1 140
Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle. 139
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 139
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 135
AN IN VIVO EXPERIMENTAL METHOD TO PREDICT THE TORSADOGENIC POTENTIALITY OF DRUGS: EVALUATION OF QT PROLONGATION IN ANAESTHETISED GUINEA-PIG 131
Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives. 131
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 129
Flavonoids and mitochondrial pharmacology: A new paradigm for cardioprotection 129
A NEW NITRIC OXIDE RELEASING ANTI-DIABETIC HYBRID DRUG: FROM THE DESIGN TO THE PHARMACOLOGICAL CHARACTERIZATION 128
Mitochondrial Potassium Channels as Pharmacological Target for Cardioprotective Drugs 124
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 121
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 119
Anti-ischemic properties of a new spiro-cyclic benzopyran activator of the cardiac mito-KATP channel 119
Valore nutraceutico dei flavonoidi presenti nel genere Citrus. Evidenze epidemiologiche, cliniche e pre-cliniche degli effetti protettivi dei Citrus flavanoni sulle funzioni cardiovascolari 118
Anticancer properties of erucin, an H2S-releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC-1) 118
R+-METHANANDAMIDE INHIBITS TRACHEAL RESPONSE TO ENDOGENOUSLY RELEASED ACETYLCHOLINE VIA CAPSAZEPINE-SENSITIVE RECEPTORS 117
NOVEL ANALGESIC/ANTI-INFLAMMATORY AGENTS: 1,5-DIARYLPYRROLE NITROOXYALKYL ETHERS AND RELATED COMPOUNDS AS CYCLOOXYGENASE-2 INHIBITING NITRIC OXIDE DONORS 116
VASORELAXATION BY HYDROGEN SULPHIDE INVOLVES ACTIVATION OF KV7 POTASSIUM CHANNELS 115
R(+)-METHANANDAMIDE INHIBITS EFS-INDUCED CHOLINERGIC RESPONSE IN GUINEA-PIG TRACHEA THROUGH A VR-MEDIATED MECHANISM 114
QT PROLONGATION IN GUINEA PIGS FOR PRELIMINARY SCREENING OF TORSADOGENICITY OF DRUGS AND DRUG-CANDIDATES. II 114
Synthesis and evaluation of multi-functional NO-donor/insulin-secretagogue derivatives for the treatment of type II diabetes and its cardiovascular complications 114
Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? 113
Voltage-operated potassium (Kv) channels contribute to endothelium-dependent vasorelaxation of carvacrol on rat aorta 111
New Benzopyran-Based Openers of the Mitochondrial ATP-Sensitive Potassium Channel with Potent Anti-Ischemic Properties 110
Spirocyclic Benzopyran-based derivatives as new anti-ischemic activators of mitochondrial ATP-sensitive potassium channel 109
SYNTHESIS AND BETA-BLOCKING ACTIVITY OF (R,S)-(E)-OXIMEETHERS OF 2,3-DIHYDRO-1,8-NAPHTHYRIDINE AND 2,3-DIHYDROTHIOPYRANO[2,3-B]PYRIDINE: IDENTIFICATION OF BETA 3-ANTAGONISTS 108
Impact of mucoadhesive polymeric nanoparticulate systems on oral bioavailability of a macromolecular model drug 108
(+/-)-NARINGENIN AS LARGE CONDUCTANCE Ca2+-ACTIVATED K+ (BKCa) CHANNEL OPENER IN VASCULAR SMOOTH MUSCLE CELLS 108
VASODILATOR ACTIVITY OF MICHELIA FIGO SPRENG (MAGNOLIACEAE) BY IN VITRO FUNCTIONAL STUDY 107
Cardiac ATP-sensitive potassium channels, a potential target for an anti-ischaemic pharmacological strategy 105
The nutraceutical value of olive oil and its bioactive constituents on the cardiovascular system. Focusing on main strategies to slow down its quality decay during production and storage 104
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP MODELS FOR PREDICTING BIOLOGICAL PROPERTIES, DEVELOPED BY COMBINING STRUCTURE- AND LIGAND-BASED APPROACHES: AN APPLICATION TO THE HUMAN ETHER-A-GO-GO-RELATED GENE POTASSIUM CHANNEL INHIBITION 103
Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels 102
ANTI-ISCHEMIC PROPERTIES OF A NEW SPIRO-CYCLIC BENZOPYRAN ACTIVATOR OF CARDIAC MITOCHONDRIAL ATP-SENSITIVE POTASSIUM CHANNELS 101
Vasodilator activity of crude methanolic extract of Gentiana Kokiana Perr Et Song (Gentianaceae) 101
VASORELAXATION BY HYDROGEN SULPHIDE INVOLVES ACTIVATION OF KV7 POTASSIUM CHANNELS 100
Evaluation of the NO-releasing properties of NO-donor linkers 100
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors. 100
TORSADOGENIC CARDIOTOXICITY OF ANTIPSYCHOTIC DRUGS: A STRUCTURAL FEATURE, POTENTIALLY INVOLVED IN THE INTERACTION WITH CARDIAC HERG POTASSIUM CHANNELS 99
Novel 1,4-benzothiazine derivatives as large conductance Ca(2+)-activated potassium channel openers 98
ANTI-ISCHEMIC ACTIVITY OF AN ANTIOXIDANT ALDOSE REDUCTASE INHIBITOR ON DIABETIC AND NON-DIABETIC RAT HEARTS 96
VASORELAXANT EFFECTS OF THE CHLOROFORMIC CRUDE EXTRACT OF BUPLEURUM FRUTICOSUM L. (UMBELLIFERAE) ROOTS ON RAT THORACIC AORTA 95
QT PROLONGATION IN ANAESTHETIZED GUINEA-PIGS: AN EXPERIMENTAL APPROACH FOR PRELIMINARY SCREENING OF TORSADOGENICITY OF DRUGS AND DRUG CANDIDATES 94
Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties 94
Functional contribution of the endothelial component to the vasorelaxing effect of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels 93
Pharmacological study on the cardiovascular activity of no-sartans, pharmacodynamic hybridsexhibiting at1-antagonist and no-donor properties 92
null 92
Mitochondriotropic and Cardioprotective Effects of Triphenylphosphonium-Conjugated Derivatives of the Diterpenoid Isosteviol 92
NO-glibenclamide derivatives: prototypes of a new class of nitric oxide-releasing anti-diabetic drugs 92
null 91
null 91
Matrix metalloproteinase-12 inhibitors: synthesis, structure-activity relationships and intestinal absorption of novel sugar-based biphenylsulfonamide carboxylates 90
APRIKALIM ABOLISHES THE QT INTERVAL PROLONGATION THIORIDAZINE-INDUCED BY THE ACTIVATION OF SARCOPLASMIC KATP CHANNELS 89
Synthesis and evaluation of antihypertensive activity of 1,8-naphthyridine derivatives. Part X 89
Eruca sativa Mill. seed extract promotes anti-obesity and hypoglycemic effects in mice fed with a high-fat diet 88
Effect of glucoraphanin and sulforaphane against chemotherapy-induced neuropathic pain: Kv7 potassium channels modulation by H2S release in vivo 87
Protective Effects of Bergamot (Citrus bergamia Risso & Poiteau) Juice in Rats Fed with High-Fat Diet 87
HYDROGEN SULPHIDE: NOVEL OPPORTUNITY FOR DRUG DISCOVERY 85
IMPROVING THE SOLUBILITY OF A NEW CLASS OF ANTIINFLAMMATORY PHARMACODYNAMIC HYBRIDS, THAT RELEASE NITRIC OXIDE AND INHIBIT CYCLOXYGENASE-2 ISOENZYME 84
The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction 84
H2S-RELEASING PROPERTIES OF NEW THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES 83
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 83
Structure-activity relationships study of isothiocyanates for H2S releasing properties: 3-Pyridyl-isothiocyanate as a new promising cardioprotective agent 83
The Renal Outer Medullary Potassium channel (ROMK): an intriguing pharmacological target for an innovative class of diuretic drugs 82
Anti-ischemic properties of new spiro-morpholine benzopyrane derivatives, potential activators of mitochondrial atp-sensitive potassium channel, on isolated rat hearts 80
Enantioselectivity in Cardioprotection induced by (S)- (-)-2,2-Dimethyl-N-(4'-acetamido-benzyl)-4-spiromorpholone-chromane 80
SYNTHESIS AND BIOLOGICAL EVALUATION OF 5-MEMBERED SPIRO HETEROCYCLE-BENZIPYRAN DERIVATIVES AGAINST MYOCARDIAL ISCHEMIA 79
A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis 79
ACTIVATION OF VASCULAR KV7 POTASSIUM CHANNELS CONTRIBUTES TO THE VASODILATOR EFFECTS OF HYDROGEN SULPHIDE 78
null 78
NOVEL ANALGESIC/ANTI-INFLAMMATORY AGENTS: DIARYLPYRROLE ACETIC ACID ESTERS ENDOWED WITH NITRIC OXIDE RELEASING PROPERTIES 78
New spiromorpholone- and spiromorpholine-benzopyrane derivatives as potential activators of mito-KATP channel 77
HIGHLY POTENT KATP CHANNEL ACTIVATORS 76
HIGHLY POTENT 1,4-BENZOTHIAZINE DERIVATIVES AS K(ATP)-CHANNEL OPENERS 76
Erucin exhibits vasorelaxing effects and antihypertensive activity by H 2 S-releasing properties 76
ROLE OF BK POTASSIUM CHANNELS IN THE VASORELAXING EFFECTS OF FLAVONOIDS 75
THE XANTHONES GENTIACAULEIN AND GENTIAKOCHIANIN ARE RESPONSIBLE FOR THE VASODILATOR ACTION OF THE ROOTS OF GENTIANA KOCHIANA 74
Cardioprotective effects of different flavonoids against myocardial ischemia/reperfusion injury in Langendorff-perfused rat hearts. 74
ATTIVATORI DEI CANALI KATP A STRUTTURA 1,4-BENZOTIAZINICA: MODIFICAZIONI IN C-2 E C-6 73
IDENTIFICATION OF "TOXICOPHORIC" FEATURES FOR PREDICTING DRUG-INDUCED QT INTERVAL PROLONGATION 73
Ex vivo and in vivo study of sucrosomial® iron intestinal absorption and bioavailability 73
CARDIOVASCULAR EFFECT OF URTICA DIOICA (URTICACEAE) ROOT EXTRACTS: IN VITRO AND IN VIVO PHARMACOLOGICAL STUDIES 72
A Nutraceutical Strategy to Slowing Down the Progression of Cone Death in an Animal Model of Retinitis Pigmentosa 72
By-products from winemaking and olive mill value chains for the enrichment of refined olive oil: Technological challenges and nutraceutical features 72
THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES: CHEMOTYPES OF SLOW H2S-RELEASING AGENTS 70
null 70
EFFECTS OF KATP OPENERS ON THE QT PROLONGATION INDUCED BY HERG-BLOCKING DRUGS IN GUINEA-PIGS 70
Pathophysiological role of mitochondrial potassium channels and their modulation by drugs 70
Development of fortified citrus olive oils: From their production to their nutraceutical properties on the cardiovascular system 70
NATURAL AND SYNTHETIC POTASSIUM CHANNEL ACTIVATORS 69
Totale 10301
Categoria #
all - tutte 21456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21456


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018198 0000 00 00 353012310
2018/20191730 28143920 15328 46540 44310335254
2019/20202831 345198257193 250287 329223 26919321176
2020/20211616 126938273 130129 116149 21814590265
2021/20221952 381626177 339301 56108 7455146535
2022/20232430 314367183225 310367 55193 416000
Totale 13621